<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="4548">
  <stage>Registered</stage>
  <submitdate>17/07/2014</submitdate>
  <approvaldate>17/07/2014</approvaldate>
  <nctid>NCT02196649</nctid>
  <trial_identification>
    <studytitle>Clip Placement Following Endoscopic Mucosal Resection - Randomised Trial</studytitle>
    <scientifictitle>Prophylactic and Endoscopic Clip Placement to Prevent Clinically Significant Post Wide Field Endoscopic Mucosal Resection Bleeding - a Randomised Controlled Trial.</scientifictitle>
    <utrn />
    <trialacronym>CuRB</trialacronym>
    <secondaryid>HREC2014/5/4.2(3971)</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Colonic Polyps</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Bowel - Back passage (rectum) or large bowel (colon)</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Endoscopic Clip

Experimental: Endoscopic Clipping - Participants randomised to the arm will receive endoscopic clips to their defect following EMR.

No Intervention: No Endoscopic Clipping - These participants will receive standard of care practice only.


Treatment: devices: Endoscopic Clip


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Post-Procedural Bleeding - Clinically significant post colonic wide-field EMR bleeding (CSPEB)</outcome>
      <timepoint>14 days</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Safety success - Safety - admission rates, adverse outcomes, deaths Rate of initial technical success Duration of procedure Recurrence rate</outcome>
      <timepoint>18 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Can give informed consent to trial participation

          -  Lesion size greater than 20 mm

          -  Lesion proximal to and inclusive of mid transverse colon

          -  Laterally spreading or sessile polyp morphology</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>99</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Previous resection or attempted resection of lesion

          -  Clip deployed prior to the completion of the EMR

          -  Major intraprocedural bleeding not treatable by coagulation

          -  Endoscopic appearance of invasive malignancy

          -  Age less than 18 years

          -  Pregnancy

          -  Active Inflammatory colonic conditions (e.g. inflammatory bowel disease)

          -  Use of anticoagulant or antiplatelet agents other than aspirin less than 5 days prior
             to procedure

          -  American Society of Anesthesiology (ASA) Grade IV-V</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/10/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>300</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/11/2019</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Westmead Endoscopy Unit - Westmead</hospital>
    <postcode>2145 - Westmead</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Professor Michael Bourke</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>Patients will be randomised to have endoscopic clips applied to the Endoscopic Mucosal
      Resection (EMR) site following complete removal of the lesion, or will not receive clips and
      proceed with standard of care.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02196649</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Michael J Bourke, MBBS</name>
      <address>Western Sydney Local Health District</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>